The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
@Dactions - your observations IMO opinion are right.
The only thing I would add is, the stage of the commercial deal is relevant to the stage of the regulatory approval in the region and the whether they can launch or not. The commercial deals hence are quite different, when comparing EU/UK to to the other regions
- The Atlantis, serving China and S.E Asia; Labatec Pharma, serving Middle East ; M8 Pharmaceuticals, serving Brazil and Mexico, all have in common is the regulatory approval in those regions is still needed. The deal structure would be different to UK / EU. The time to launch therefore is different and not dependent on having manufacturing, marketing, supply chains in places for these regions (they will come later)
- The UK / EU - in contrast to the above is in quite a different stage IMO. I also feel it is linked somewhat to the US regulatory process, as may pharma / distributors can distribute to both regions (but of course that impacts EU / UK Launch). In the EU/ UK, they can launch as Reg approval is in place. IMO, it is also important to make sure the due diligence on marketing, manufacturing / supply chain, EU Regs after Brexit, etc is good to go (which can take time) and can deliver when launched, it is critical as this region can go when they want as they have Reg approval. Too soon in the EU and they dont have things ready, wont be good. Also, don't forget it is OTC, so the supply chain and retailers / pharmacies, those involved is much larger that non OTC.
The EU/UK is a stark contrast to the other regions, in the other regions, there is time before they get to this stage, therefore the commercial deal is different, the negotiation is different.
The EU/ UK commercial negotiations / deal will only be strengthened by how well FUM can be prepared and ready to go for launch and the US Reg outcome.
All IMO of course.
@Ybhere - agreed, i don't think it is end the last of him,
@Bucolic - Many many folks on here over a lot of time have contributed to tackling Liambooth, kudos to all and appreciate the effort of all those. Personally, especially your good self and The Italian for your extraordinary efforts.
Hopefully we don't see him back, but i have my doubts, and suspect he will reappear under another handle.
All the Best for the festive period, I am out next week anyway and be back when i can.
What is not to love – Eroxon /MED3000 - HERE ARE THE FACTS
- Eroxon going to market. VERY VERY SOON
- FIRST GEL FOR ED TO OTC MARKET - NO OTHER GELS CAN . NO COMPETITION. NO BRAINER
- $3.6 billion market & conservative 5% share of that estimated as min
- Can be used with other products / medicine or recreationally (as some would)
- Better safety profile that NSAIDS (Cialis, Viagra etc)
- EU approved, US approval in process, Global approvals ongoing
- UK / EU partnership / launch COMING SOON
- South America and Mexico launch and cash inflows COMING SOON
- China and SE Asia launch and cash inflows COMING SOON
- US go ahead COMING SOON
- Patent application in progress using patent lawyers - COMING SOON
- Will help ED sufferers - COMING SOON TO MILLIONS of ED SUFFERERS GLOBALLY
- Fast-acting and helps you get an erection within 10 minutes. (FASTER THAN CIALIS, VIAGRA ETC)
- First fast-acting topical gel for erectile dysfunction available WITHOUT A DOCTORS PRESCRIPTION in Europe and the UK.
- Eroxon® is clinically proven to treat erectile dysfunction and following a large Phase 3 clinical trial was approved in April 2021 for marketing in the EU and UK.
Circumstances explained her https://eroxon.com/ and summed up well here
sums up pretty well
https://www.trinitydelta.org/research-notes/nearing-the-critical-point-in-erectile-dysfunction/
Liambooth joined LSE March 2021 when Fum spiked in price
- Same time in March 2021 Fum was shorted "Fum have 5.7m shares out on loan (being shorted) which is 2.08% of the total share allocation."
- Since March 2021 Liambooth has posted 1000+ negative posts on LSE, misleading, distorted and untrue claims with no real hard evidence of anything.
- Liambooth posted hundreds more negative posts on ADVN, and no posts before March 2021 neither, check yourselves
- He ain't a LTH, he lying to you all.
- He clearly is a stock basher. Lying and deceiving in his posts
So don't entertain or believe a word he is saying, he is a proven share basher.
LSE won't do a thing.
I must apologise to Bucolic and the Italian, i have been missing in action from this Board last few days, through reasons of work mainly. and afraid my absence will continue, I am out all next week too.
I apologise not because it is my duty to be here (or theirs), but i don't think people realise how much time and effort it takes to respond to all the share bashing, and they have been taking the burden here of posting and challenging posts whilst i was out.
We are not paid unlike some to do this, but compelled to do so, as ignoring him has not worked in the past, and any one new / existing PI coming here and believing a word he says is just determent to the understanding and this BB.
FUM have done F all, i emailed them, neither have LSE, its clear as day he is disrupting this BB and is a share basher, maybe they forgot it is illegal, and keep saying FUM should contact them. Well they have not even though i repeatedly asked.
So keep posting maybe these below to keep the real factual information at the top
PS I don't give F for those that say we are spoiling this BB, and have the cheek to call us muppets (when we put the effort in to challenge the lies) maybe you should do one instead) or have the balls to do research and challenge him.
What is not to love – Eroxon /MED3000 - HERE ARE THE FACTS
- Eroxon going to market. VERY VERY SOON
- FIRST GEL FOR ED TO OTC MARKET - NO OTHER GELS CAN . NO COMPETITION. NO BRAINER
- $3.6 billion market & conservative 5% share of that estimated as min
- Can be used with other products / medicine or recreationally (as some would)
- Better safety profile that NSAIDS (Cialis, Viagra etc)
- EU approved, US approval in process, Global approvals ongoing
- UK / EU partnership / launch COMING SOON
- South America and Mexico launch and cash inflows COMING SOON
- China and SE Asia launch and cash inflows COMING SOON
- US go ahead COMING SOON
- Patent application in progress using patent lawyers - COMING SOON
- Fast-acting and helps you get an erection within 10 minutes. (FASTER THAN CIALIS, VIAGRA ETC)
- First fast-acting topical gel for erectile dysfunction available WITHOUT A DOCTORS PRESCRIPTION in Europe and the UK.
- Eroxon® is clinically proven to treat erectile dysfunction and following a large Phase 3 clinical trial was approved in April 2021 for marketing in the EU and UK.
PS have i mentioned to you all (IMPORTANT FACTS ABOUT SHAREBASHER LIAMBOOTH)
Liambooth joined LSE March 2021 when Fum spiked in price
- Same time in March 2021 Fum was shorted "Fum have 5.7m shares out on loan (being shorted) which is 2.08% of the total share allocation."
- Since March 2021 Liambooth has posted 1000+ negative posts on LSE, misleading, distorted and untrue claims with no real hard evidence of anything.
- Liambooth posted hundreds more negative posts on ADVN, and no posts before March 2021 neither, check yourselves
- He ain't a LTH, he lying to you all.
- He clearly is a stock basher.
"Its just a placebo effect"
How did the experts quote the following, they should have just gone to the Share Basher Liambooth
“The efficacy of MED3000 is remarkable and approaches the efficacy of current first line therapy but with significantly lower adverse events. With topical application, it will be of particular appeal to patients who want a fast onset of action. Lack of drug interactions with prescription products will enable the product to be used with other medications such as nitrates and other cardiovascular drugs. It can also be used in conjunction with other ED products to improve overall efficacy to patients. As such MED3000 will be of great interest to the medical community.”
Professor David Ralph
Consultant Urologist at University College London and past president of the European Society of Sexual Medicine
=========
“All formulations tested in FM57, including the control product DermaSys®, have demonstrated positive and statistically significant efficacy results against baseline data together with an excellent safety profile,”
“The DermaSys® product will be of high interest to the Medical Community for those patients who seeking a rapid onset of action and a very low side-effect profile. It will likely find use in the substantial number of patients, especially those with ED of a mild to moderate nature and those patients who are contraindicated for use with existing products.”
Said Dr. Yacov Reisman, Consultant Urologist and president of the European Society of Sexual Medicine.
========
“In my humble opinion and as an expert in the field of erectile dysfunction management, I am very supportive of MED3000 and do believe that it offers an important and valid addition to the armamentarium of treatments we can offer our patients for erectile dysfunction”
Professor Arthur Burnett
Johns Hopkins University School of Medicine, Baltimore, US
MD, MBA, FACS, Patrick C Walsh Distinguished Professor of Urology
Past President of the Sexual Medicine Society of North America
As per the patent the cooling and warming effects start early (within a minute if I remember correctly) and go on for several minutes.
Whereas the massaging is for 15 secs to apply the gel
So what is lasting longer? and causing the results in IEFF SEP2 and SEP3?
It is not the massaging / manual stimulation.
f your suggesting they massaged more than 15 seconds and staff instructed them to do that, then you are implying break of GCP practise and breach of protocol, by multiple Inv sites and staff.
Re statement "And we were not told what the men reported doing after the 15 seconds of massage to the 10 minutes it took for 60% to report an effect. Did they go watch the News on TV? Did they go watch some else stimulating? Did they continue manual stimulation on their own? Did their partners do more stimulation either physically or visually?
It's change from baseline, so they did what they would do normally when trying to have sexual intercourse, like they did during the baseline period when they tried having sex, they did what ever they do, again during the 12 week treatment phase . They were not instructed to do something different from the bassline period except apply the gel for 15 seconds.
What you are suggesting / questioning that something was suspect happening between 15 seconds and 10 minutes, is total rubbish.
PS where is the clinical data for your claim as i asked in my previous posts
To reiterate it is not just onset time that is measure d to compare to MED3000 its IEFF, SEP 2 and Sep3
Sexual Encounter Profile question 3 (SEP3) "Did your erection last long enough for you to have sexual intercourse?"
Patient's response to SEP2 "Were you able to insert your p***s into your partner's v****a?,"
The International Index of Erectile Function (IIEF-EF)- https://www.urologypartners.co.uk/repository/originals/The_International_Index_of_Erectile_Function.pdf
Liambooth posted: “ The glans ***** is very highly innervated and there are sensors which are reactive to a range of physical sensations, including touch, pressure and temperature”
"So any lubricant that is massaged in and has a cooling/rewarming sensation can reproduce an equivalent effect to MED3000"
I have asked many times before if you can share the clinical data that shows said lubricant in a trial, demonstrating improved IEFF Sep2 and Sep3 significant improvement compared to 4 week baseline after a 12 week treatment with said lubricant.
We can compare it to results from FM57 for MED3000
If you have the data to back up your claims, do share it.
And further more your statement just now "No the clear winner was how soon the manual stimulation occurred. "
You denied earlier TODAY, that you did claim it was manual stimulation that led to improvement. See below.
Liambooth, Posts: 1,086, Price: 33.00, No Opinion, RE: Who gets it up quickest? Today 13:08:
And I an not “ claiming the results in improvement of ED in the FM57 clinical trial are all because of the 15 second manual rubbing of the gel and not because of the of MED3000.
Do you want to make your mind up and lets us know once and for all, whether you are claiming it or not. Because it is more and more lies you are getting caught up in again and again since March. .
This is just one example of hundreds you have been caught up in so far..
it's compared to baseline, and significant change to baseline - for the thousandth time
in the baseline, nothing is given and they try having intercourse for 4 weeks at least four times and record things like onset, stiffness, penetrations, etc etc.
So of course, in the 12 week treatment phase with Med3000 the changes from baseline were significant compare to the 4 week baseline period. including onset, IEFF, Sep 3, Sep 4. etc
Do you really think when they tried intercourse in the baseline period, the ED sufferers did did not touch themselves to get hard?
Re "No the clear winner was how soon the manual stimulation occurred. " - total BS and no evidence at all provided to match the claim. Show us the proof where is says it was the massaging that led to significant change from baseline in the trial.
Show us the proof where is says it was the massaging that led to significant change from baseline in the trial.
Where did i write they should be dismissed? Again more lies.
I said both articles were anonymous as in the real identity of the author of each is unknown. Twisting it all again and again.
Also as I said the "Point is still valid as the discussion was around disclaimers and your were quick to point out repeatedly Trinity and Fum have disclaimers, but never acknowledge the disclaimer on all your links and posts including those two articles."
Have you read the patent ( I know you have) - In there is clearly says and FUM acknowledge
2. A composition according to claim 1, wherein the composition is free of GTN, sildenafil and an acetylcholinesterase inhibitor, or derivatives or prodrugs thereof.
3, A composition according to claim 1 or 2, wherein the composition does not contain any pharmaceutically active ingredients for the treatment of erectile dysfunction.
So they don't put it on the Website. It is in the public domain. Everyone knows. Regulatory bodies, experts, public, investors, FUM, the fricking world knows. You have no point.
I know what a pseudonym, the article is by Neuroskeptic. I get this,
But his real identity?
Point is still valid as the discussion was around disclaimers and your were quick to point out repeatedly Trinity and Fum have disclaimers, but never acknowledge the disclaimer on all your links and posts including those two articles.
Its clear some are trying to misleading, lying and share bashing...that is a quid pro Quo ( I really know it is not unlike some)
ROFLMAO wetting pants and quoting Lincoln.
ABOUT LIAMBOOTH
Liambooth joined LSE March 2021 when Fum spiked in price
- Same time in March 2021 Fum was shorted "Fum have 5.7m shares out on loan (being shorted) which is 2.08% of the total share allocation."
- Since March 2021 Liambooth has posted 1000+ negative posts on LSE, misleading, distorted and untrue claims with no real hard evidence of anything.
- Liambooth posted hundreds more negative posts on ADVN, and no posts before March 2021 neither, check yourselves
- He ain't a LTH, he lying to you all.
- He clearly is a stock basher. Lying and deceiving in his posts
So don't entertain or believe a word he is saying, he is a proven share basher.
LSE won't do a thing.